TriSalus Life Sciences
TLSI
TLSI
59 hedge funds and large institutions have $44.6M invested in TriSalus Life Sciences in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $46.8M → $44.6M (-$2.25M)
3.48% less ownership
Funds ownership: 22.7% → 19.22% (-3.5%)
Holders
59
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.61M | |
| 2 | +$773K | |
| 3 | +$622K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$462K |
| 5 |
State Street
Boston,
Massachusetts
|
+$358K |
Top Sellers
| 1 | -$214K | |
| 2 | -$178K | |
| 3 | -$112K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$105K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$35.9K |
